Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Clinical efficacy of the composite end point of death, myocardial infarction (MI), urgent target vessel revascularization (TVR), and bailout to open-label treatment for thrombosis; secondary end point of 30-day death, MI, and urgent TVR; and 48-h death or MI by tertile of index activated clotting time (ACT).
|
